The Product
ExoStat previously developed an FDA cleared-to-market device to measure pC02 in oral mucosal tissue. The company is currently developing a hands free monitoring system that employs a new technology platform at the point of care. The MicroTrend™ System provides an early warning of potential hypoperfusion and rapidly delivers otherwise unavailable data to care providers in critical care environments.

"The Health of tissues in critically ill patients is fundamental in determining the optimal approach to management. Mucosal tissue pCO2 is a vital data element essential to make that assessment"

Dr. Paul E. Marik, MD. FCCP, FCCM
Professor of Medicine, Eastern Virginia Medical School
Researcher, Author, ICU Physician